Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial-Reference-Cited by-同舟云学术

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

Published:2019-09-24 Issue:2 Volume:16 Page:452-459
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Matson Mark A.¹,Schenker Eran²,Stein Michal²,Zamfirova Vladislava³,Nguyen Huy-Binh³^ORCID,Bergman Garrett E.³

Affiliation:

1. Investigator. Prism Research, St. Paul, MN, USA

2. Department of Medical Affairs, Kamada Ltd, Beit Kama, MP Negev, Israel

3. Department of Medical Affairs, Kedrion Biopharma Inc, Fort Lee, NJ, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1656967

Reference46 articles.

1. Intimate Partner Violence during Pregnancy and Postpartum Depression in Japan: A Cross-sectional Study

2. Human Rabies in China, 1960-2014: A Descriptive Epidemiological Study

3. The Importance of Wild Canids in the Epidemiology of Rabies in Northeast Brazil: A Retrospective Study

4. Why has canine rabies remained endemic in the Kilosa district of Tanzania? Lessons learnt and the way forward

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies;Vaccine;2024-09

2. Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial;Clinical Infectious Diseases;2024-03-13

3. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults;Vaccine;2023-12

4. Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults;Human Vaccines & Immunotherapeutics;2023-11-03

5. Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting;Current Pain and Headache Reports;2022-11-23